Clinical Trial Results: Study of PDA-002 in Subjects With Peripheral Arterial Disease and Diabetic Foot Ulcers [Phase 1]

View source ↗

Summary

Phase 1 trial results for PDA-002 in peripheral arterial disease and diabetic foot ulcers have been completed with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Diabetic Foot Ulcer
• Peripheral Arterial Disease

Drugs mentioned

• PDA-002

Snippet

Sponsor: Celularity Incorporated | Conditions: Peripheral Arterial Disease, Diabetic Foot Ulcer | Phase 1 | Status: COMPLETED | Results posted: 2026-06-04